Search results
Results from the WOW.Com Content Network
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment . The company was founded in 1998 and went public in 2004.
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018. This means hedge funds […] is Halozyme Therapeutics, Inc ...
Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Halozyme Therapeutics Inc (NASDAQ:HALO), with a market capitalization of US$2.2b, rarely draw their ...
Last week, two major events shook up the market for breast cancer treatments. Shares of Halozyme Therapeutics and Roche rose on the EU approval of subcutaneous Herceptin, while Eli Lilly fell ...
What: Shares of Halozyme Therapeutics climbed as. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they ...
Halozyme Therapeutics has had an incredible year, rallying more than 100% since the beginning of 2013. However, the ride up has been a very bumpy one, due to two major developments involving its ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us